Isolated from an Ebola survivor, mAb 3A6 binds to the virus's "stalk," blocking infection. It offers effective protection in non-human primates at low doses, which could reduce treatment costs.
More than 40 years after it was identified, the Ebola virus continues to defy drugs, treatment plans—and experts’ best efforts to solve its mysteries. Ebola vaccine has to be kept cold.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback